Search Results for 'Tavr'

Tavr published presentations and documents on DocSlides.

Mitigating Stroke Risk in TAVR:

celsa-spraggs
0 Slides

Important Considerations . as TAVR Moves to . Low...

TAVR and the Risk of Thrombosis

briana-ranney
0 Slides

Program Goals. Thromboembolic Risk Associated Wit...

The Process of TAVR Development

kinohear
17 Slides

Stanton J Rowe. CEO. NXT Biomedical. I, Stanton Ro...

“TAVR: Transcatheter Treatment of Aortic Stenosis Comes of Age

priscilla
23 Slides

”. Muhammad Raza, MD, FACC, FSCAI, RPVI.. Interv...

Do We Have Enough TAVR Centers?

amelia
23 Slides

A Heart Team Perspective. Interventional cardiolog...

Adnan H. Siddiqui, MD , PhD

trish-goza
0 Slides

Professor & Vice-Chairman Department of Neuro...

Anticoagulants in Interventional Cardiology:

trish-goza
0 Slides

Overview of Anticoagulation in . Interventional C...

Adapting to Change in Structural Heart Disease Training

priscilla
15 Slides

Michael Mack, MD. Baylor Scott & White Health....

Edwards 2017 Healthcare Leadership Series

isabella2
19 Slides

Shilpa Shelton, MBA. Program Director, . Bluhm. C...

5-Year Clinical and Echocardiographic Outcomes from the Randomized SURTAVI Trial

SocialButterfly
24 Slides

Nicolas M. Van Mieghem, MD, PhD. For the SURTAVI T...

Valve Reoperation after Native and Valve-in-Valve Transcatheter Aortic Valve Replacement: A Statewi

sophia2
15 Slides

Shinichi Fukuhara, MD . (. 1,4,5). , Stephane Leun...

Dual Anti-Platelet Therapy After TAVR?

salem
13 Slides

By: Cole Smith PharmD Candidate 2021. University o...

Primary Results From the Evolut Low Risk Bicuspid Study

cody
27 Slides

Evolut. Low Risk Bicuspid Study. Basel Ramlawi, M...

Balloon-Expandable TAVR in Inoperable Patients With Severe

tatiana-dople
66 Slides

The PARTNER Trial Cohort B 2-Year Results. The in...

Balloon-Expandable TAVR in Inoperable Patients With Severe

celsa-spraggs
71 Slides

The PARTNER Trial Cohort B 2-Year Results. The in...

The DEFLECT III Trial:

pasty-toler
35 Slides

A Prospective Randomized Evaluation of the . TriG...

1 Safety and Quality in the Cardiothoracic

faustina-dinatale
17 Slides

Operating Room. Engy Hanna. , MD . Director, Card...

Structural Heart Live Cases

cheryl-pisano
0 Slides

Supported by:. Medtronic inc. Bard Inc. Teru...

General anesthesia versusconscious sedation intranscatheter aortic val

molly
5 Slides

10.4172/Interventional-Cardiology.1000623

Leadership Project: Transcatheter

elena
11 Slides

Aortic Valve Replacement Resource Manual. Molina A...

Critical Review of the Evidence:

emily
22 Slides

TAVR in Low-Risk Bicuspid in Patients. John Forres...

Principles of Reimbursement

Pirateking
21 Slides

“Back to the basics” – Coding Documentation,...

Primary Results From the EvolutLow Risk Bicuspid StudyBasel Ramlawi M

candy
27 Slides

1 Disclosure Statement of Financial InterestsWithi...

Howard C. Herrmann, MD, FACC, MSCAI

yvonne
29 Slides

John . Bryfogle. Professor of Cardiovascular Medi...

Mind the gap: avoiding paravalvular leak using computer simulation in bicuspid transcatheter aortic

brooke
13 Slides

EHJ-CR-D-22-00342. July 2022. Introduction. EHJ-CR...

CRITICAL AORTIC STENOSIS: ECMO USED IN MORE WAYS THAN ONE

eddey
11 Slides

Gregory Condos, MD, LCDR, MC, USN; Katherine Rees;...

Two-year Clinical and Echocardiographic Outcomes from the PARTNER 3 Low-risk Randomized Trial

braylen673
26 Slides

Low-risk Randomized Trial. Michael J. Mack, . MD &...